Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free RANI Stock Alerts

Rani Therapeutics (RANI) Earnings Date, Estimates & Call Transcripts

Rani Therapeutics logo
$0.96 +0.01 (+1.31%)
As of 02:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Rani Therapeutics Earnings Summary

Rani Therapeutics released Q1 2026 earnings on May 15, 2026, reporting an EPS of -$0.04, which beat the consensus estimate of -$0.06 by $0.02. Quarterly revenue was reported to be $1.71 million, above analysts' expectations of $1.13 million. With a trailing EPS of -$0.41, Rani Therapeutics' earnings are expected to grow next year, from ($0.24) to ($0.20) per share.

Upcoming Q2
Earnings Date
Aug. 6Before Market OpensEstimated
Consensus EPS
(May. 15)
-$0.06
Actual EPS
(May. 15)
-$0.04 Beat By $0.02
Actual Revenue
(May. 15)
$1.71M

Q1 2026 Earnings Resources

RANI Upcoming Earnings

Rani Therapeutics' next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules.

Powered by Quartr
Get Rani Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rani Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RANI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RANI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rani Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.06-$0.06-$0.06
Q2 20261-$0.07-$0.07-$0.07
Q3 20261-$0.07-$0.07-$0.07
Q4 20261-$0.07-$0.07-$0.07

Rani Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026
(Estimated)		--------
5/15/2026Q1 2026-$0.06-$0.04+$0.02-$0.04$1.13M$1.71M
3/26/2026Q4 2025-$0.03-$0.07 -$0.04-$0.07$5.00M$1.46M
11/6/2025Q3 2025-$0.09-$0.12 -$0.03-$0.12$10.00M-
8/7/2025Q2 2025-$0.19-$0.18+$0.01-$0.18--
5/13/2025Q1 2025-$0.22-$0.22--$0.22-$0.20M
3/31/2025Q4 2024-$0.24-$0.27 -$0.03-$0.27-$1.03M
8/6/2024--$0.29-$0.26+$0.03-$0.26--

Data powered by Fiscal.ai.

Rani Therapeutics Earnings - Frequently Asked Questions

Rani Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 6th, 2026 based off last year's report dates. Learn more on RANI's earnings history.

In the previous quarter, Rani Therapeutics (NASDAQ:RANI) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.02. Learn more on analysts' earnings estimate vs. RANI's actual earnings.

Rani Therapeutics (NASDAQ:RANI) has a recorded annual revenue of $1.63 million.

Rani Therapeutics (NASDAQ:RANI) has a recorded net income of -$29.67 million. RANI has generated -$0.41 earnings per share over the last four quarters.

Rani Therapeutics' earnings are expected to grow from ($0.24) per share to ($0.20) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:RANI) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel